دورية أكاديمية

Plasma levels of E‐selectin are associated with retinopathy in sickle cell disease.

التفاصيل البيبلوغرافية
العنوان: Plasma levels of E‐selectin are associated with retinopathy in sickle cell disease.
المؤلفون: Agouti, Imane, Masson, Elodie, Loundou, Anderson, Jean, Estelle, Arnaud, Laurent, Abdili, Evelyne, Berenger, Patricia, Lavoipierre, Virginie, Séguier, Julie, Dignat‐George, Françoise, Lacroix, Romaric, Bernit, Emmanuelle
المصدر: European Journal of Haematology; Mar2023, Vol. 110 Issue 3, p271-279, 9p
مصطلحات موضوعية: SICKLE cell anemia, OCULAR injuries, VASCULAR endothelium, LEG ulcers, ENDOTHELIAL cells
مستخلص: Background: The vascular endothelium is markedly disrupted in sickle cell disease (SCD) and is the converging cascade of the complex pathophysiologic processes linked to sickle cell vasculopathy. Circulating endothelial activation and/or apoptotic markers may reflect this endothelial activation/damage that contributes to the pathophysiology of the SCD vascular complications. Methods: Plasmatic levels of circulating endothelial cells (CECs), E‐selectin, progenitor's endothelial cells (EPCs), and circulating extracellular vesicles (EVs) were evaluated in 50 SCD patients, 16 with vasculopathy. The association between these markers and the occurrence of disease‐related microvascular injuries of the eye (retinopathy), kidney (nephropathy), and skin (chronic active ulcers) was explored. Results: Among the endothelial activation markers studied, only higher plasma levels of E‐selectin were found in SCD patients with vasculopathy (p =.015). Increased E‐selectin levels were associated with retinopathy (p <.001) but not with nephropathy or leg ulcers. All patients, at steady state, with or without vasculopathy, did not display a high count of CEC and EPC, markers of endothelial injury and repair. We did not show any significant differences in EVs levels between vasculopathy and not vasculopathy SCD patients. Conclusions: Further studies will be required to determine whether the E‐selectin could be used as an early biomarker of retinopathy sickle cell development. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Haematology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09024441
DOI:10.1111/ejh.13902